Our current in vivo results are consistent with recent findings in MCF7 and MDA-MB-468 cells, two human breast cancer cell lines in culture, which showed significant reductions in the CD44(+)/CD24(-/low) CSC population, after treatment with doxycycline (17). This evidence concerns the gene CD24 and breast carcinoma.